Credit Suisse Reiterates Neutral Rating, Raises Price Target On CME Group Following Financials Conference


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


In a report published Wednesday, Credit Suisse analyst Christian Bolu reiterated a Neutral rating on

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

CME Group Inc (NASDAQ: CME), and raised the price target from $90.00 to $95.00.In the report, Credit Suisse noted, "Marking to market our estimates for quarter-to-date volume trends, we raise our 1Q/2015 estimates to $0.96/$3.71 (old: $0.93/$3.70). Our 2016/2017 estimates are unchanged at $4.10/$4.25. Our revised $95 (old: $90) per share target price implies CME shares are able to trade at 23x our 2016 EPS estimate. We currently rate CME shares at Neutral— while we appreciate CME's diverse product set, best-in-class distribution/clearing platforms and strong free cash flow generation prospects, we see more balanced risk/reward at current valuations."CME Group closed on Tuesday at $94.20.
Posted In: Analyst ColorPrice TargetAnalyst RatingsChristian BoluCredit Suisse